Edition:
United Kingdom

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

0.48USD
19 Jul 2018
Change (% chg)

$0.01 (+3.23%)
Prev Close
$0.47
Open
$0.48
Day's High
$0.48
Day's Low
$0.48
Volume
700
Avg. Vol
39,629
52-wk High
$3.02
52-wk Low
$0.44

Chart for

About

Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC)... (more)

Overall

Beta: -0.71
Market Cap(Mil.): $25.24
Shares Outstanding(Mil.): 14.43
Dividend: --
Yield (%): --

Financials

  DFFN.OQ Industry Sector
P/E (TTM): -- 85.36 32.76
EPS (TTM): -1.86 -- --
ROI: -143.79 2.21 14.61
ROE: -221.11 3.85 16.34

BRIEF-Diffusion Pharmaceuticals Files Prospectus Related To Offering Of Common Stock

* DIFFUSION PHARMACEUTICALS INC FILES PROSPECTUS RELATED TO OFFERING UP TO 12.3 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING‍​ Source text: (http://bit.ly/2nGHE9Q) Further company coverage:

06 Feb 2018

Earnings vs. Estimates